Last updated: July 22, 2024
Sponsor: Kessler Foundation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asperger's Disorder
Williams Syndrome
Treatment
KF-STRIDE®
Clinical Study ID
NCT06380569
E-1139-21 Community Setting
Ages 14-26 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Lives in the United States of America Between the ages of 14-26 Speaks English well and at a 4th grade reading level
Exclusion
Exclusion Criteria:
Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy) Has a history of significant psychiatric illness(like schizophrenia or psychosis) Has uncontrolled seizures or other unstable medical complications
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: KF-STRIDE®
Phase:
Study Start date:
July 01, 2024
Estimated Completion Date:
December 01, 2025
Study Description
Connect with a study center
Kessler Foundation
East Hanover, New Jersey 07936
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.